1 Min Read
Nov 27 (Reuters) - Swedish Orphan Biovitrum:
* SAYS WINS APPROVAL FROM HEALTH CANADA FOR ORFADIN ORAL SUSPENSION FOR TREATMENT OF HT-1 Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.